BELLEVUE GROUP AG – Celldex Therapeutics, Inc. Transaction History
BELLEVUE GROUP AG portfolio value:
$50.59M
portfolio value
BELLEVUE GROUP AG quarter portfolio value change:
+4.27%
quarter
Celldex Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +94.59% | 875K shares | 25.66M | $28.11 | 1.8M |
| Q2 2022 | share | Increase | 0.00% | 925K shares | 24.93M | $26.96 | 925K |